Salt Lake City, Utah. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery Akoya, UCSF and the I-SPY TRIAL

New capacity will serve unmet need in COVID-19 testing infrastructure CARLSBAD, CA – Argonaut Manufacturing Services, a contract manufacturing organization

The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA) AUSTIN,

High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim,

Gaithersburg, MD, and Vancouver, Canada – Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the

Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the iPLEX®

MOUNTAIN VIEW, California, June 2, 2020  – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease

– CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology – Precision NanoSystems will lead RNA vaccine formulation

Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities   Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a